vs

Side-by-side financial comparison of HARROW, INC. (HROW) and System1, Inc. (SST). Click either name above to swap in a different company.

HARROW, INC. is the larger business by last-quarter revenue ($89.1M vs $51.9M, roughly 1.7× System1, Inc.). HARROW, INC. runs the higher net margin — 7.4% vs -26.0%, a 33.4% gap on every dollar of revenue. On growth, HARROW, INC. posted the faster year-over-year revenue change (33.3% vs -31.3%). Over the past eight quarters, HARROW, INC.'s revenue compounded faster (60.5% CAGR vs -21.8%).

Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.

System1 is an American Internet advertising company. Formerly known as OpenMail, it was founded in 2013. It describes itself as operating a "Responsive Acquisition Marketing Platform", and cites privacy as one of its principal foci, although it has been criticized for its influence on privacy-focused properties, including search engine Startpage.com. It is headquartered in Marina del Rey, California.

HROW vs SST — Head-to-Head

Bigger by revenue
HROW
HROW
1.7× larger
HROW
$89.1M
$51.9M
SST
Growing faster (revenue YoY)
HROW
HROW
+64.6% gap
HROW
33.3%
-31.3%
SST
Higher net margin
HROW
HROW
33.4% more per $
HROW
7.4%
-26.0%
SST
Faster 2-yr revenue CAGR
HROW
HROW
Annualised
HROW
60.5%
-21.8%
SST

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HROW
HROW
SST
SST
Revenue
$89.1M
$51.9M
Net Profit
$6.6M
$-13.5M
Gross Margin
79.3%
41.0%
Operating Margin
17.5%
-33.6%
Net Margin
7.4%
-26.0%
Revenue YoY
33.3%
-31.3%
Net Profit YoY
-2.2%
4.8%
EPS (diluted)
$0.20
$-3.58

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HROW
HROW
SST
SST
Q4 25
$89.1M
$51.9M
Q3 25
$71.6M
$61.6M
Q2 25
$63.7M
$78.1M
Q1 25
$47.8M
$74.5M
Q4 24
$66.8M
$75.6M
Q3 24
$49.3M
$88.8M
Q2 24
$48.9M
$94.6M
Q1 24
$34.6M
$84.9M
Net Profit
HROW
HROW
SST
SST
Q4 25
$6.6M
$-13.5M
Q3 25
$1.0M
$-18.5M
Q2 25
$5.0M
$-17.5M
Q1 25
$-17.8M
$-15.9M
Q4 24
$6.8M
$-14.2M
Q3 24
$-4.2M
$-23.6M
Q2 24
$-6.5M
$-26.4M
Q1 24
$-13.6M
$-10.5M
Gross Margin
HROW
HROW
SST
SST
Q4 25
79.3%
41.0%
Q3 25
75.3%
36.9%
Q2 25
74.5%
35.7%
Q1 25
67.5%
38.2%
Q4 24
78.8%
42.1%
Q3 24
75.6%
28.0%
Q2 24
74.4%
27.6%
Q1 24
69.5%
21.9%
Operating Margin
HROW
HROW
SST
SST
Q4 25
17.5%
-33.6%
Q3 25
20.6%
-25.3%
Q2 25
17.9%
-20.4%
Q1 25
-23.5%
-17.6%
Q4 24
19.3%
-15.7%
Q3 24
2.7%
-24.6%
Q2 24
3.1%
-30.8%
Q1 24
-20.0%
-30.4%
Net Margin
HROW
HROW
SST
SST
Q4 25
7.4%
-26.0%
Q3 25
1.4%
-30.1%
Q2 25
7.8%
-22.4%
Q1 25
-37.2%
-21.3%
Q4 24
10.1%
-18.7%
Q3 24
-8.6%
-26.6%
Q2 24
-13.2%
-27.9%
Q1 24
-39.2%
-12.4%
EPS (diluted)
HROW
HROW
SST
SST
Q4 25
$0.20
$-3.58
Q3 25
$0.03
$-2.30
Q2 25
$0.13
$-2.23
Q1 25
$-0.50
$-0.21
Q4 24
$0.19
$-3.41
Q3 24
$-0.12
$-3.37
Q2 24
$-0.18
$-3.80
Q1 24
$-0.38
$-0.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HROW
HROW
SST
SST
Cash + ST InvestmentsLiquidity on hand
$72.9M
$86.9M
Total DebtLower is stronger
$250.0M
$305.1M
Stockholders' EquityBook value
$52.4M
$30.5M
Total Assets
$399.5M
$405.0M
Debt / EquityLower = less leverage
4.77×
10.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HROW
HROW
SST
SST
Q4 25
$72.9M
$86.9M
Q3 25
$74.3M
$54.6M
Q2 25
$53.0M
$63.6M
Q1 25
$66.7M
$43.9M
Q4 24
$47.2M
$63.6M
Q3 24
$72.6M
$69.1M
Q2 24
$71.0M
$75.7M
Q1 24
$76.0M
$69.9M
Total Debt
HROW
HROW
SST
SST
Q4 25
$250.0M
$305.1M
Q3 25
$347.2M
$259.2M
Q2 25
$250.6M
$263.3M
Q1 25
$256.9M
$267.4M
Q4 24
$262.7M
$255.1M
Q3 24
$230.7M
$259.2M
Q2 24
$236.3M
$263.3M
Q1 24
$243.4M
$268.6M
Stockholders' Equity
HROW
HROW
SST
SST
Q4 25
$52.4M
$30.5M
Q3 25
$47.0M
$42.7M
Q2 25
$49.7M
$58.2M
Q1 25
$56.5M
$67.2M
Q4 24
$69.7M
$80.3M
Q3 24
$58.0M
$90.3M
Q2 24
$58.5M
$109.4M
Q1 24
$60.6M
$131.7M
Total Assets
HROW
HROW
SST
SST
Q4 25
$399.5M
$405.0M
Q3 25
$363.1M
$385.2M
Q2 25
$345.0M
$429.2M
Q1 25
$364.2M
$419.2M
Q4 24
$389.0M
$459.1M
Q3 24
$351.5M
$479.3M
Q2 24
$306.6M
$511.3M
Q1 24
$295.5M
$521.1M
Debt / Equity
HROW
HROW
SST
SST
Q4 25
4.77×
10.01×
Q3 25
7.39×
6.07×
Q2 25
5.05×
4.53×
Q1 25
4.55×
3.98×
Q4 24
3.77×
3.18×
Q3 24
3.98×
2.87×
Q2 24
4.04×
2.41×
Q1 24
4.02×
2.04×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HROW
HROW
SST
SST
Operating Cash FlowLast quarter
$8.4M
$-10.6M
Free Cash FlowOCF − Capex
$8.1M
FCF MarginFCF / Revenue
9.1%
Capex IntensityCapex / Revenue
0.4%
0.0%
Cash ConversionOCF / Net Profit
1.27×
TTM Free Cash FlowTrailing 4 quarters
$43.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HROW
HROW
SST
SST
Q4 25
$8.4M
$-10.6M
Q3 25
$16.6M
$-2.1M
Q2 25
$-803.0K
$24.5M
Q1 25
$19.7M
$-15.9M
Q4 24
$-17.8M
$772.0K
Q3 24
$3.0M
$-5.0K
Q2 24
$-2.7M
$10.0M
Q1 24
$-4.6M
$-16.0M
Free Cash Flow
HROW
HROW
SST
SST
Q4 25
$8.1M
Q3 25
$16.4M
Q2 25
$-969.0K
Q1 25
$19.5M
$-16.0M
Q4 24
$-18.3M
Q3 24
$2.3M
$-36.0K
Q2 24
$-3.1M
Q1 24
$-4.7M
FCF Margin
HROW
HROW
SST
SST
Q4 25
9.1%
Q3 25
22.9%
Q2 25
-1.5%
Q1 25
40.8%
-21.5%
Q4 24
-27.4%
Q3 24
4.8%
-0.0%
Q2 24
-6.3%
Q1 24
-13.6%
Capex Intensity
HROW
HROW
SST
SST
Q4 25
0.4%
0.0%
Q3 25
0.3%
0.0%
Q2 25
0.3%
0.0%
Q1 25
0.4%
0.1%
Q4 24
0.8%
0.0%
Q3 24
1.2%
0.0%
Q2 24
0.7%
0.0%
Q1 24
0.3%
0.0%
Cash Conversion
HROW
HROW
SST
SST
Q4 25
1.27×
Q3 25
16.26×
Q2 25
-0.16×
Q1 25
Q4 24
-2.62×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons